Mecobalamin improved pernicious anemia in an elderly individual with Hashimoto's disease and diabetes mellitus

Japanese Journal of Geriatrics

Volumn 50, Issue 4, 2013, Pages 542-545

  Izumi, Kenichi ^a   Fujise, Takehiro ^a   Inoue, Kanako ^a   Mori, Hitoe ^a   Yamazaki, Kouta ^a   Hongou, Yui ^a   Takagi, Satoko ^a   Yamanouchi, Hiroko ^a   Ashida, Kenji ^a   Anzai, Keizo ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Diabetes mellitus; Elderly; Hashimoto's disease; Oral vitamin B12 treatment; Pernicious anemia

Indexed keywords

CYANOCOBALAMIN; DRUG DERIVATIVE; MECOBALAMIN;

AGED; ARTICLE; CASE REPORT; HASHIMOTO DISEASE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PERNICIOUS ANEMIA;

ADMINISTRATION, ORAL; AGED; ANEMIA, PERNICIOUS; DIABETES MELLITUS, TYPE 2; HASHIMOTO DISEASE; HUMANS; MALE; VITAMIN B 12;

EID: 84884363178     PISSN: 03009173     EISSN: None     Source Type: Journal    
DOI: 10.3143/geriatrics.50.542     Document Type: Article

References (16)

1. Emmanuel A, Khalid S: Optimal management of pernicious anemia. Journal of Blood Medline 2012; 3: 97-103.
2. Clarke R, Grimley EJ, Schneede J, Nexo E, Bates C, Fletcher A, et al.: Vitamin B12 and folate deficiency in later life. Age Ageing 2004; 33 (1): 34.
3. Minot GR, Murphy WP: Treatment of Pernicious Anemia by a Special Diet. Yale J Bil Med 2001; 74 (5): 341-353.
4. Takasaki Y, Moriuchi Y, Tsushima H, Ikeda E, Koura S, Taguchi J, et al.: Effectiveness of oral vitamin B12 therapy for pernicious anemia and vitamin B12 deficiency anemia. Rinsho Ketsueki 2002; 43 (3): 165-169.
5. Butler CC, Vidal-Alaball J, Cannings-John R, McCaddon A, Hood K, Papaioannou A, et al.: Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials. Fam Pract 2006; 23 (3): 279-285.
6. den Elzen WP, Gussekloo J: Anaemia in older persons. Neth J Med 2011; 69 (6): 260-267.
7. Fernández BF, Monzón H, Forné M: A short review of malabsorption and anemia. World J Gastroenterol 2009; 15 (37): 4644-4652.
8. Yang DT, Cook RJ: Spurious elevations of vitamin B12 with pernicious anemia. N Engl J Med 2012; 366 (18): 1742-1743.
9. Kaferle J, Strzoda CE: Evaluation of macrocytosis. Am Fam Physician 2009; 79 (3): 203-208.
10. Dali YN, Andrès E: An update on cobalamin deficiency in adults. QJM 2009; 102 (1): 17-28.
11. Pflipsen MC, Oh RC, Saguil A, Seehusen DA, Seaquist D, Topolski R: The prevalence of vitamin B12 deficiency in patients with type 2 diabetes: a cross-sectional study. J Am Board Fam Med 2009; 22 (5): 528-534.
12. de Jager J, Kooy A, Lehert P, Wulffelé MG, van der Kolk J, Bets D, et al.: Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ 2010; 340: c2181.
13. Carmel R: How I treat cobalamin (vitamin B12) deficiency. Blood 2008; 112: 2214.
14. Carmel R: Reassessment of the relative prevalences of antibodies to gastric parietal cell and to intrinsic factor in patients with pernicious anaemia: influence of patient age and race. Clin Exp Immunol 1992; 89: 74.
15. Bolaman Z, Kadikoylu G, Yukselen V, Yavasoglu I, Barutca S, Senturk T: Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. Clin Ther 2003; 25 (12): 3124-3134.
16. Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J: Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998; 92 (4): 1191-1198.